Comparing the H1 profile of second-generation antihistamines

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 55, Issue 60, 2000, Pages 40-45

  Frossard, N ^a   Walsh, G M ^b  

^a INSERM   (France)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; EBASTINE; EPINASTINE; FEXOFENADINE; HISTAMINE; LORATADINE; TERFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALLERGIC DISEASE; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HUMAN; NOSE ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SKIN ALLERGY; CLINICAL TRIAL; COMPARATIVE STUDY; HAY FEVER; IMMEDIATE TYPE HYPERSENSITIVITY; PATHOLOGY; SKIN; TREATMENT OUTCOME;

CETIRIZINE; CLINICAL TRIALS; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; RHINITIS, ALLERGIC, SEASONAL; SKIN; TREATMENT OUTCOME;

EID: 0034106216     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. SIMONS FE, MCMILLAN JL, SIMONS KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-547.
2. FROSSARD N, MELAC M, BENABDESSALAM O, PAULI G. Consistency of the efficacy of cetirizine and ebastine on skin reactivity. Ann Allergy Asthma Immunol 1998;80:61-65.
3. PUROHIT A, DUVERNELLE C, MELAC M, BENABDESSELAM O, PAULI G, FROSSARD N. Consistency and efficacy of cetirizine 10 mg vs ebastine 20 mg at 4 hours on skin reactivity. Eur J Clin Pharmacol 1999;55:589-592.
4. COULIE PJ, DE VOS C, GHYS L, RIHOUX J-P. Pharmacologic modulation by cetirizine 2HCl and loratadine of the histamine-induced skin reaction in mice and in humans. Drug Dev Res 1989;17:199-206.
5. VAN NESTE D, DE BROUWER B, TASST C, et al. Laser Doppler flowmetry on histamine-induced skin response. Eur J Dermatol 1995;5:537-541.
6. DE LA CUADRA J, TERUEL M, TEIXIDO P, et al. Assessment of the wheal size and skin blood flow of the erythema induced by histamine and its modification with cetirizine and ebastine: a crossover, double blind study. Dermatology 1994;188:131-134.
7. DAY JH, BRISCOE MP, WELSH A, et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 1997;79:533-540.
8. 1-blockade effect of fexofenadine. Ann Allergy Asthma Immunol 1997;79:530-532.
9. GRANT JA, DANIELSON L, RIHOUX J-P, DE VOS C. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy 1999;54:700-707.
10. BRAUNSTEIN G, MALAQUIN F, FAJAC I, MELAC M, FROSSARD N. Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis. Br J Clin Pharmacol 1992;33:445-448.
11. FROSSARD N, LACRONIQUE J, MELAC M, et al. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis. Allergy 1997;52:205-209.
12. FROSSARD N, BENABDESSELAM O, MELAC M, GLASSER N, LACRONIQUE J, PAULI G. The nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis. Am J Ther 1998;5:307-311.
13. 1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol 1993;91:1005-1014.
14. DE BLAY F, KRIEGER P, SPIRLET F, et al. Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels. Int Arch Allergy Immunol 1999;120:158-165.
15. KASSEL O, DE BLAY F, DUVERNELLE C, et al. Nerve growth factor (NGF) expression after repeated inhalations of low subclinical doses of cat allergen in asthma. Am J Respir Crit Care Med 1999;159:A334.
16. MONROE EW, DALY AF, SHALHOUB RF. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. J Allergy Clin Immunol 1997;99:798-806.
17. DAY JH, BRISCOE MP, CLARK RH, ELLIS AK, GERVAIS P. Onset of action and efficacy of terfenadine, astemizole, cetirizine and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:163-172.